{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:16:37Z","timestamp":1792606597035,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:00:00Z","timestamp":1622592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:00:00Z","timestamp":1622592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To date, very few studies focused their attention on efficacy and safety of recanalisation therapy in acute ischemic stroke (AIS) patients with cancer, reporting conflicting results. We retrospectively analysed data from our database of consecutive patients admitted to the Udine University Hospital with AIS that were treated with recanalisation therapy, i.e. intravenous thrombolysis (IVT), mechanical thrombectomy (MT), and bridging therapy, from January 2015 to December 2019. We compared 3-month dependency, 3-month mortality, and symptomatic intracranial haemorrhage (SICH) occurrence of patients with active cancer (AC) and remote cancer (RC) with that of patients without cancer (WC) undergoing recanalisation therapy for AIS. Patients were followed up for 3\u00a0months. Among the 613 AIS patients included in the study, 79 patients (12.9%) had either AC (<jats:italic>n<\/jats:italic>\u2009=\u200946; 7.5%) or RC (<jats:italic>n<\/jats:italic>\u2009=\u200933; 5.4%). Although AC patients, when treated with IVT, had a significantly increased risk of 3-month mortality [odds ratio (OR) 6.97, 95% confidence interval (CI) 2.42\u201320.07, p\u2009=\u20090.001] than WC patients, stroke-related deaths did not differ between AC and WC patients (30% vs<jats:italic>.<\/jats:italic> 28.8%, p\u2009=\u20090.939). There were no significant differences between AC and WC patients, when treated with MT\u2009\u00b1\u2009IVT, regarding 3-month dependency, 3-month mortality and SICH. Functional independence, mortality, and SICH were similar between RC and WC patients. In conclusion, recanalisation therapy might be used in AIS patients with nonmetastatic AC and with RC. Further studies are needed to explore the outcome of AIS patients with metastatic cancer undergoing recanalisation therapy.<\/jats:p>","DOI":"10.1038\/s41598-021-91257-5","type":"journal-article","created":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T10:08:04Z","timestamp":1622628484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Recanalisation theraphy for acute ischemic stroke in cancer patients"],"prefix":"10.1038","volume":"11","author":[{"given":"Giovanni","family":"Merlino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Smeralda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luigi","family":"Gigli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Lorenzut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Surcinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Maniaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosaria","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,2]]},"reference":[{"key":"91257_CR1","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1212\/01.WNL.0000129912.56486.2B","volume":"62","author":"DM Cestari","year":"2004","unstructured":"Cestari, D. M., Weine, D. M., Panageas, K. S., Segal, A. Z. & DeAngelis, L. M. Stroke in patients with cancer: Incidence and etiology. Neurology 62, 2025\u20132030 (2004).","journal-title":"Neurology"},{"key":"91257_CR2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.clineuro.2005.03.008","volume":"108","author":"SH Li","year":"2006","unstructured":"Li, S. H. et al. Incidence of ischemic stroke post-chemotherapy: A retrospective review of 10,963 patients. Clin. Neurol. Neurosurg. 108, 150\u2013156 (2006).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"91257_CR3","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/ijs.12124","volume":"9","author":"EJ Lee","year":"2014","unstructured":"Lee, E. J. et al. Ischemic stroke in patients with cancer: Is it different from usual strokes?. Int. J. Stroke 9, 406\u2013412 (2014).","journal-title":"Int. J. Stroke"},{"key":"91257_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ana.24325","volume":"77","author":"BB Navi","year":"2015","unstructured":"Navi, B. B. et al. Association between incident cancer and subsequent stroke. Ann. Neurol. 77, 291\u2013300 (2015).","journal-title":"Ann. Neurol."},{"key":"91257_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5853\/jos.2016.00570","volume":"19","author":"MJ Lee","year":"2017","unstructured":"Lee, M. J. et al. Hypercoagulability and mortality of patients with stroke and active cancer: The OASIS-CANCER study. J. Stroke 19, 77\u201387 (2017).","journal-title":"J. Stroke"},{"key":"91257_CR6","first-page":"1250","volume":"31","author":"A Arboix","year":"2000","unstructured":"Arboix, A. Cerebrovascular disease in the cancer patient. Rev. Neurol. 31, 1250\u20131252 (2000).","journal-title":"Rev. Neurol."},{"key":"91257_CR7","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.11.003","volume":"24","author":"AG Karli\u0144ska","year":"2015","unstructured":"Karli\u0144ska, A. G., Gromadzka, G., Karli\u0144ski, M. A. & Cz\u0142onkowska, A. The activity of malignancy may determine stroke pattern in cancer patients. J. Stroke Cerebrovasc. Dis. 24, 778\u2013783 (2015).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"91257_CR8","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.05.009","volume":"28","author":"A Chatterjee","year":"2019","unstructured":"Chatterjee, A. et al. Temporal trends in the use of acute recanalization therapies for ischemic stroke in patients with cancer. J. Stroke Cerebrovasc. Dis. 28, 2255\u20132261 (2019).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"91257_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.10.010","volume":"20","author":"S Masrur","year":"2011","unstructured":"Masrur, S. et al. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy. J. Stroke Cerebrovasc. Dis. 20, 124\u2013130 (2011).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"91257_CR10","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jocn.2014.09.016","volume":"22","author":"SB Murthy","year":"2015","unstructured":"Murthy, S. B. et al. In-hospital outcomes of thrombolysis for acute ischemic stroke in patients with primary brain tumors. J. Clin. Neurosci. 22, 474\u2013478 (2015).","journal-title":"J. Clin. Neurosci."},{"key":"91257_CR11","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/ijcp.12586","volume":"69","author":"P Sobolewski","year":"2015","unstructured":"Sobolewski, P., Brola, W., Szczuchniak, W., Fudala, M. & Sobota, A. Safety of intravenous thrombolysis for acute ischaemic stroke including concomitant neoplastic disease sufferers\u2014experience from Poland. Int. J. Clin. Pract. 69, 666\u2013673 (2015).","journal-title":"Int. J. Clin. Pract."},{"key":"91257_CR12","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1177\/1591019918776207","volume":"24","author":"S Jung","year":"2018","unstructured":"Jung, S. et al. Procedural and clinical outcomes of endovascular recanalization therapy in patients with cancer-related stroke. Interv. Neuroradiol. 24, 520\u2013528 (2018).","journal-title":"Interv. Neuroradiol."},{"key":"91257_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/1747493018778135","volume":"14","author":"ER Weeda","year":"2019","unstructured":"Weeda, E. R. & Bohm, N. Association between comorbid cancer and outcomes among admissions for acute ischemic stroke receiving systemic thrombolysis. Int. J. Stroke 14, 48\u201352 (2019).","journal-title":"Int. J. Stroke"},{"key":"91257_CR14","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.05.018","volume":"28","author":"F Sallustio","year":"2019","unstructured":"Sallustio, F. et al. Safety and efficacy of reperfusion therapies for acute ischemic stroke patients with active malignancy. J. Stroke Cerebrovasc. Dis. 28, 2287\u20132291 (2019).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"91257_CR15","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1007\/s00415-019-09416-8","volume":"266","author":"D Lee","year":"2019","unstructured":"Lee, D. et al. Intra-arterial thrombectomy for acute ischaemic stroke patients with active cancer. J. Neurol. 266, 2286\u20132293 (2019).","journal-title":"J. Neurol."},{"key":"91257_CR16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s10072-019-04103-y","volume":"41","author":"BH Cho","year":"2020","unstructured":"Cho, B. H. et al. Outcomes of endovascular treatment in acute ischemic stroke patients with current malignancy. Neurol. Sci. 41, 379\u2013385 (2020).","journal-title":"Neurol. Sci."},{"key":"91257_CR17","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/ijs.12369","volume":"9","author":"T Steiner","year":"2014","unstructured":"Steiner, T., Al-Shahi Salman, R. & Ntaios, G. The European Stroke Organization (ESO) guidelines. Int. J. Stroke 9, 838\u2013839 (2014).","journal-title":"Int. J. Stroke"},{"key":"91257_CR18","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STROKEAHA.118.022606","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers, W. J. et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 50, e344\u2013e418 (2019).","journal-title":"Stroke"},{"key":"91257_CR19","first-page":"1534","volume":"22","author":"JH Pexman","year":"2001","unstructured":"Pexman, J. H. et al. Use of the Alberta stroke program early CT score (ASPECTS) for assessing CT scans in patients with acute stroke. Am. J. Neuroradiol. 22, 1534\u20131542 (2001).","journal-title":"Am. J. Neuroradiol."},{"key":"91257_CR20","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"M Oken","year":"1982","unstructured":"Oken, M. et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am. J. Clin. Oncol. 5, 649\u2013655 (1982).","journal-title":"Am. J. Clin. Oncol."},{"key":"91257_CR21","first-page":"653","volume":"30","author":"M Zacharakis","year":"2010","unstructured":"Zacharakis, M. et al. Predictors of survival in stage IV metastatic colorectal cancer. Anticancer Res. 30, 653\u2013660 (2010).","journal-title":"Anticancer Res."},{"key":"91257_CR22","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1007\/s00384-019-03430-y","volume":"34","author":"O Abdel-Rahman","year":"2019","unstructured":"Abdel-Rahman, O. ECOG performance score 0 versus 1: Impact on efficacy and safety of first-line 5-FU-based chemotherapy among patients with metastatic colorectal cancer included in five randomized trials. Int. J. Colorectal Dis. 34, 2143\u20132150 (2019).","journal-title":"Int. J. Colorectal Dis."},{"key":"91257_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams, H. P. Jr. et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24, 35\u201341 (1993).","journal-title":"Stroke"},{"key":"91257_CR24","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/jama.1995.03530130023023","volume":"274","author":"W Hacke","year":"1995","unstructured":"Hacke, W. et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274, 1017\u20131025 (1995).","journal-title":"JAMA"},{"key":"91257_CR25","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","volume":"359","author":"W Hacke","year":"2008","unstructured":"Hacke, W. et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 359, 1317\u20131329 (2008).","journal-title":"N. Engl. J. Med."},{"key":"91257_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000339675","volume":"34","author":"RC Seet","year":"2012","unstructured":"Seet, R. C. & Rabinstein, A. A. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: A critical review of case definitions. Cerebrovasc. Dis. 34, 106\u2013114 (2012).","journal-title":"Cerebrovasc. Dis."},{"key":"91257_CR27","doi-asserted-by":"publisher","first-page":"e00418","DOI":"10.1002\/brb3.418","volume":"6","author":"G Tsivgoulis","year":"2016","unstructured":"Tsivgoulis, G., Safouris, A., Katsanos, A. H., Arthur, A. S. & Alexandrov, A. V. Mechanical thrombectomy for emergent large vessel occlusion: A critical appraisal of recent randomized controlled clinical trials. Brain Behav. 6, e00418 (2016).","journal-title":"Brain Behav."},{"key":"91257_CR28","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1055\/s-0030-1255224","volume":"30","author":"LR Rogers","year":"2010","unstructured":"Rogers, L. R. Cerebrovascular complications in patients with cancer. Semin. Neurol. 30, 311\u2013319 (2010).","journal-title":"Semin. Neurol."},{"key":"91257_CR29","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1161\/STROKEAHA.118.023044","volume":"50","author":"J Yoo","year":"2019","unstructured":"Yoo, J., Nam, H. S., Kim, Y. D., Lee, H. S. & Heo, J. H. Short-term outcome of ischemic stroke patients with systemic malignancy. Stroke 50, 507\u2013511 (2019).","journal-title":"Stroke"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-91257-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-91257-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-91257-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T09:13:10Z","timestamp":1670058790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-91257-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,2]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["91257"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-91257-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,2]]},"assertion":[{"value":"7 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11634"}}